Skip to main content
. 2020 Aug 15;12(8):2295. doi: 10.3390/cancers12082295

Figure 3.

Figure 3

Expression of ZKSCAN3 in radical prostatectomy specimens. (A) Representative images of immunohistochemistry in benign prostatic tissue (original magnification: ×400), HGPIN (original magnification: ×400), and prostatic adenocarcinoma (original magnification: ×200). Kaplan-Meier analyses for recurrence-free survival, according to the levels (0: n = 21; 1+: n = 99; 2+: n = 95; 3+: n = 85) of ZKSCAN3 expression in carcinoma (B) or a known history of vasectomy (n = 14) (C). Biochemical recurrence after radical prostatectomy was defined as a single prostate-specific antigen (PSA) level of ≥0.2 ng/mL.